JP2010512361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512361A5 JP2010512361A5 JP2009540659A JP2009540659A JP2010512361A5 JP 2010512361 A5 JP2010512361 A5 JP 2010512361A5 JP 2009540659 A JP2009540659 A JP 2009540659A JP 2009540659 A JP2009540659 A JP 2009540659A JP 2010512361 A5 JP2010512361 A5 JP 2010512361A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- autoimmune
- syndrome
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0624874.4A GB0624874D0 (en) | 2006-12-13 | 2006-12-13 | Treatment |
| GB0624874.4 | 2006-12-13 | ||
| PCT/EP2007/010904 WO2008071418A2 (en) | 2006-12-13 | 2007-12-12 | Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512361A JP2010512361A (ja) | 2010-04-22 |
| JP2010512361A5 true JP2010512361A5 (enExample) | 2011-02-10 |
| JP5414532B2 JP5414532B2 (ja) | 2014-02-12 |
Family
ID=37712062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540659A Expired - Fee Related JP5414532B2 (ja) | 2006-12-13 | 2007-12-12 | 免疫グロブリンＧ媒介性疾患を治療するためのエンドグリコシダーゼＥｎｄｏＳの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8889128B2 (enExample) |
| EP (1) | EP2099477B1 (enExample) |
| JP (1) | JP5414532B2 (enExample) |
| CN (1) | CN101605557B (enExample) |
| AU (1) | AU2007331736B2 (enExample) |
| CA (1) | CA2671736C (enExample) |
| ES (1) | ES2426352T3 (enExample) |
| GB (1) | GB0624874D0 (enExample) |
| WO (1) | WO2008071418A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008136735A1 (en) | 2007-05-04 | 2008-11-13 | Nilsson Kurt G I | Material for separation of a biomolecule |
| GB0821100D0 (en) * | 2008-11-18 | 2008-12-24 | Hansa Medical Ab | Antibodies |
| WO2011059385A1 (en) * | 2009-11-13 | 2011-05-19 | Bengt Guss | Immunizing composition for reducing streptococcal infections |
| US9333252B2 (en) | 2010-05-26 | 2016-05-10 | Intervacc Ab | Vaccine against streptococcal infections based on recombinant proteins |
| GB201103780D0 (en) | 2011-03-04 | 2011-04-20 | Hansa Medical Ab | Treatment for ige-mediated disease |
| GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
| GB201201314D0 (en) * | 2012-01-26 | 2012-03-07 | Isis Innovation | Composition |
| EP2812442B9 (en) * | 2012-02-10 | 2023-02-15 | University of Maryland, Baltimore | Chemoenzymatic glycoengineering of antibodies and fc fragments thereof |
| TWI682033B (zh) | 2014-03-17 | 2020-01-11 | 泉盛生物科技股份有限公司 | 製造具有經修飾的糖苷化作用之重組糖蛋白之方法 |
| GB201413240D0 (en) * | 2014-07-25 | 2014-09-10 | Hansa Medical Ab | Method |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| PL3630968T3 (pl) | 2017-05-26 | 2024-10-07 | Genovis Ab | Enzymy do analizy glikanów |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CN108623696B (zh) * | 2018-04-20 | 2021-05-28 | 江南大学 | 一种利用纤维素固定化CBD-EndoS融合酶的方法 |
| US20200165608A1 (en) * | 2018-11-23 | 2020-05-28 | Florida State University Research Foundation, Inc. | Inhibition of vascular endothelial cell-mediated phagocytic processes for treatment of demyelinating conditions |
| GB202003129D0 (en) * | 2020-03-04 | 2020-04-15 | Hansa Biopharma AB | Conditioning regimen for transplant of stem cells |
| GB202007434D0 (en) * | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Methods |
| WO2022076556A2 (en) | 2020-10-07 | 2022-04-14 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i) |
| CN113009130B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| CA3216491A1 (en) | 2021-04-16 | 2022-10-20 | Asklepios Biopharmaceutical, Inc. | Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response |
| EP4302770A1 (en) * | 2022-07-08 | 2024-01-10 | Hansa Biopharma AB | Regimen for enzymatic desensitisation |
| EP4739775A1 (en) * | 2023-07-07 | 2026-05-13 | Emory University | Recombinant glycosidases, pharmaceutical compositions, and uses in managing autoimmune or inflammatory conditions |
| CN119709701A (zh) * | 2023-09-28 | 2025-03-28 | 上海糖岭生物医药有限责任公司 | 糖苷内切酶s2突变体、其制备方法及其在抗体糖基化改造中的应用 |
| WO2025256978A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Variants of igm and igg cleaving enzymes |
| WO2025256977A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Novel igm and igg cleaving enzymes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130228D0 (en) | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| EP1601770B1 (en) * | 2003-03-04 | 2009-09-02 | Intercell AG | Streptococcus pyogenes antigens |
| WO2006042027A2 (en) | 2004-10-08 | 2006-04-20 | Novartis Vaccines And Diagnostics Inc. | Immunogenic and therapeutic compositions for streptococcus pyogenes |
-
2006
- 2006-12-13 GB GBGB0624874.4A patent/GB0624874D0/en not_active Ceased
-
2007
- 2007-12-12 US US12/518,855 patent/US8889128B2/en active Active
- 2007-12-12 AU AU2007331736A patent/AU2007331736B2/en not_active Ceased
- 2007-12-12 JP JP2009540659A patent/JP5414532B2/ja not_active Expired - Fee Related
- 2007-12-12 CA CA2671736A patent/CA2671736C/en active Active
- 2007-12-12 EP EP07856650.2A patent/EP2099477B1/en active Active
- 2007-12-12 CN CN2007800512493A patent/CN101605557B/zh not_active Expired - Fee Related
- 2007-12-12 WO PCT/EP2007/010904 patent/WO2008071418A2/en not_active Ceased
- 2007-12-12 ES ES07856650T patent/ES2426352T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010114018A (ru) | Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства | |
| JP2014534265A5 (enExample) | ||
| JP2019031567A5 (enExample) | ||
| RU2010113964A (ru) | Применение соматостатина-14 в качестве терапевтического средства | |
| JP2014503482A5 (enExample) | ||
| ATE453669T1 (de) | Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen | |
| JP2015526440A5 (enExample) | ||
| JP2017031213A5 (enExample) | ||
| RU2010114049A (ru) | Cgrp в качестве терапевтического средства | |
| RU2010113978A (ru) | ПРИМЕНЕНИЕ Gly-Pro-Glu-OH (GPE) В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА | |
| JP2013508392A5 (enExample) | ||
| JP2015520184A5 (enExample) | ||
| JP2013535437A5 (enExample) | ||
| WO2003048327A3 (en) | Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection | |
| JP2023505492A5 (enExample) | ||
| HRP20191430T1 (hr) | Spojevi heteroarila kao inhibitori btk i njihove uporabe | |
| JP2014524748A5 (enExample) | ||
| RU2017111228A (ru) | Композиции антитела против IL-7R | |
| JP2014169326A5 (enExample) | ||
| RU2017101705A (ru) | Фармацевтическая композиция, предназначенная для применения для предупреждения и/или лечения заболевания, которое развивается или прогрессирует вследствие снижения или утраты активности фактора свертывания крови viii и/или активированного фактора свертывания крови viii | |
| WO2004041172A3 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
| JP2014519524A5 (enExample) | ||
| EA201590882A1 (ru) | Одноцепочечные аналоги инсулина длительного действия | |
| RU2014122171A (ru) | Пептидные аналоги для лечения заболеваний и расстройств | |
| RU2012148716A (ru) | Способы и композиции для улучшения оссеоинтеграции имплантата |